Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 1998, p. 1346-1349, Vol. 42, No. 6
Department of Infectious Diseases,
Received 14 October 1997/Returned for modification 18 December
1997/Accepted 10 March 1998
The aim of the present pilot study was to compare the efficacy and
safety of trimethoprim (TMP) and sulfamethoxazole (SMX) with those of
the standard therapy pyrimethamine (P)-sulfadiazine (S) for the
treatment of toxoplasmic encephalitis in patients with AIDS. This was a
pilot, multicenter, randomized, and prospective study. Patients were
randomly assigned to receive TMP (10 mg/kg of body weight/day) and SMX
(50 mg/kg/day) or P (50 mg daily) and S (60 mg/kg/day) as acute therapy
(for 4 weeks) and then as maintenance therapy for 3 months at half of
the original dosage. Seventy-seven patients were enrolled and
randomized to the study: 40 patients were treated with TMP-SMX and 37 were treated with P-S. There was no statistically significant
difference in clinical efficacy during acute therapy. In contrast,
patients randomized to TMP-SMX appeared more likely to achieve a
complete radiologic response after acute therapy. Adverse reactions
were significantly more frequent in patients treated with P-S, and skin
rash was the most common adverse event noted in these patients. In
conclusion, the results of the study suggest that TMP-SMX appears to be
a valuable alternative to P-S, in particular in patients with
opportunistic bacterial infections.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Randomized Trial of Trimethoprim-Sulfamethoxazole
versus Pyrimethamine-Sulfadiazine for Therapy of Toxoplasmic
Encephalitis in Patients with AIDS
*
Corresponding author. Mailing address: Department of
Infectious Diseases, Regional Hospital, Viale Borri 57, 21100 Varese, Italy. Phone: 0332 278446. Fax: 39332 265586.
Members of the Italian Collaborative Study Group are listed in the
Appendix.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»